Epitomee Medical Ltd
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a EPIT.TA research report →
Price Chart
About the company
Epitomee Medical Ltd develops and commercializes ingestible therapeutic devices in Israel. The company offers capsules for the treatment of overweight and obesity. It also focuses on developing biologic drug delivery solutions.
- CEO
- Radan Hashimshony
- IPO
- 2021
- Employees
- 44
- HQ
- Caesarea, HM, IL
Get TickerSpark's AI analysis on EPIT.TA
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $86.34M
- P/E
- -1.82
- PEG
- 0.00
- P/S
- 23.59
- P/B
- 1.36
- EV/EBITDA
- -1.91
- Div Yield
- 0.00%
- Gross Margin
- -218.78%
- Op Margin
- -1667.26%
- Net Margin
- -1291.98%
- ROE
- -63.16%
- ROIC
- -75.26%
Latest fiscal year · YoY change
- Revenue
- $734.68K+0.0%
- Gross Profit
- $-4,677,151-179.5%
- Op Income
- $-32,878,027
- Net Income
- $-29,704,739-457.9%
- EPS
- $-0.99-450.0%
- OCF Growth
- +19.8%
- FCF Growth
- +35.0%
- 52W High
- $1049.00
- 52W Low
- $286.00
- 50D MA
- $454.04
- 200D MA
- $706.14
- Beta
- 0.55
- RSI (14)
- 26
- Avg Volume
- 34.68K
No earnings-call transcripts are available for EPIT.TA yet.
- Free Float
- 100.0%
- Shares Outstanding
- 30.16M
- Float Shares
- 30.16M
Our EPIT.TA coverage
Recent articles, reports, and earnings notes.
No research on EPIT.TA yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate EPIT.TA report →